MIT automates lipid nanoparticle production for RNA therapies

MIT researchers have developed an automated way to produce lipid nanoparticles (LNPs) used to package RNA vaccines and nucleic acid therapeutics. The method speeds up production and gives more precise control over particle size and shape.

• Method automates production of lipid nanoparticles for RNA drugs
• Provides more precise control over particle size and shape
• MIT work could accelerate RNA vaccine and therapy development